| 摘要 |
The present invention relates to a novel manufacturing process of pharmaceutically active compound of formula I, having (6R,12a R)-configuration, used for treatment of erectile dysfunction. Starting from racemic or L-tryptophan the invention describes preparation of an enantiomerically pure intermediate of formula II which is a known precursor in the synthesis of Tadalafil (formula I).
|
